Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

41
Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within...
41
Healthcare Associated Infections II: Preventive Measures01:22

Healthcare Associated Infections II: Preventive Measures

4.9K
Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
4.9K
Antibiotic Selection00:57

Antibiotic Selection

62.2K
Overview
62.2K
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

1.9K
Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
1.9K
Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care01:30

Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care

402
A healthcare provider can diagnose a urinary tract infection (UTI) through several methods:Medical History and Symptoms: The provider will take a detailed medical history and ask about symptoms such as frequent urination, burning sensation during urination, and lower abdominal pain.Urinalysis: A clean-catch urine sample is collected in a sterile container and tested for the presence of bacteria, white blood cells (leukocytes), nitrites, blood, and protein. The presence of leukocytes and...
402
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

111
Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and...
111

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Office of the US Surgeon General Publications, 2001-2025: A Descriptive Analysis.

Public health reports (Washington, D.C. : 1974)·2026
Same author

Impact of Kaiser permanente early-onset sepsis risk calculator implementation in hospitals, England: pre-post intervention cohort analysis.

Archives of disease in childhood. Fetal and neonatal edition·2026
Same author

Building a paediatric workforce to deliver the NHS prevention agenda: time for paediatric public health medicine?

Archives of disease in childhood·2026
Same author

Carbapenem-resistant Enterobacterales across the UK: a nationwide study of carbapenemase testing and novel antimicrobial activity.

International journal of antimicrobial agents·2026
Same author

The changing landscape of outpatient antibiotic prescriptions among advanced practice clinicians in the United States, 2011 and 2022.

Antimicrobial stewardship & healthcare epidemiology : ASHE·2026
Same author

Electronic Clinical Quality Measures of Antibiotic Use in Hospitalized Adults with Uncomplicated Community-acquired Pneumonia.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026

Related Experiment Video

Updated: Apr 5, 2026

Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses
11:17

Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses

Published on: August 30, 2018

13.6K

CDC Grand Rounds: Getting Smart About Antibiotics.

Alicia Demirjian, Guillermo V Sanchez, Jonathan A Finkelstein

    MMWR. Morbidity and Mortality Weekly Report
    |August 21, 2015
    PubMed
    Summary

    Antibiotic-resistant bacteria infect two million people annually in the US, causing significant deaths and increased healthcare costs. New antibiotic development is declining despite the rise in resistant infections.

    More Related Videos

    Author Spotlight: Exploring Non-Pharmacological Therapies for Chronic Respiratory Diseases — Linking Intestinal Microbiome Insights to COPD Treatment
    03:25

    Author Spotlight: Exploring Non-Pharmacological Therapies for Chronic Respiratory Diseases — Linking Intestinal Microbiome Insights to COPD Treatment

    Published on: December 27, 2024

    1.8K
    Screening Foodstuffs for Class 1 Integrons and Gene Cassettes
    09:37

    Screening Foodstuffs for Class 1 Integrons and Gene Cassettes

    Published on: June 19, 2015

    9.5K

    Related Experiment Videos

    Last Updated: Apr 5, 2026

    Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses
    11:17

    Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses

    Published on: August 30, 2018

    13.6K
    Author Spotlight: Exploring Non-Pharmacological Therapies for Chronic Respiratory Diseases — Linking Intestinal Microbiome Insights to COPD Treatment
    03:25

    Author Spotlight: Exploring Non-Pharmacological Therapies for Chronic Respiratory Diseases — Linking Intestinal Microbiome Insights to COPD Treatment

    Published on: December 27, 2024

    1.8K
    Screening Foodstuffs for Class 1 Integrons and Gene Cassettes
    09:37

    Screening Foodstuffs for Class 1 Integrons and Gene Cassettes

    Published on: June 19, 2015

    9.5K

    Area of Science:

    • Infectious Diseases
    • Microbiology
    • Public Health

    Background:

    • Antibiotic resistance poses a growing threat, with millions infected and thousands dying annually in the US.
    • These infections lead to severe health consequences, elevated healthcare expenditures, and necessitate harsher treatments.

    Purpose of the Study:

    • To highlight the escalating crisis of antibiotic-resistant infections.
    • To underscore the critical gap between rising resistance and diminishing new antibiotic development.

    Main Methods:

    • This analysis synthesizes data on antibiotic resistance prevalence and mortality.
    • It reviews trends in emerging resistance mechanisms and new drug discovery.

    Main Results:

    • Approximately two million individuals in the US acquire antibiotic-resistant infections each year.
    • At least 23,000 deaths are directly attributed to these infections, with more fatalities from complicated conditions.
    • The development pipeline for new antibiotics has significantly slowed.

    Conclusions:

    • Antibiotic resistance is a major public health concern with severe health and economic impacts.
    • Urgent action is needed to address the declining antibiotic development pipeline amidst rising resistance.